Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anti-Cytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial to Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01108-17
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2017
Authors
Publisher
American Society for Microbiology